News
Wegovy is now the second medicine approved in the U.S. for a disease that affects millions. Novo Nordisk has several other factors working in its favor, including strong results and a solid pipeline.
Hosted on MSN30m
Voices: Is ‘black-market Ozempic’ ever worth the risk?
Aisleyne Horgan-Wallace, a former Big Brother star, had such an adverse reaction to a suspected fake weight-loss jab she ...
Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a Hold rating.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results